Frequently searched
↑ ↓ to move · Enter to open · Esc to closeSynonyms and typos are matched
Trial site
Completed
A Phase 2 Study to Evaluate the Safety and Efficacy of Pitolisant in Patients With Prader-Willi Syndrome, Followed by an Open Label Extension
NCT04257929· Phase 2· Harmony Biosciences Management, Inc.· Source
Site data: ClinicalTrials.govUpdated 12 Nov 2026
Report an error